CHECKPOINT THERAPEUTICS INC has a total of 14 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2017. It filed its patents most often in Israel, Singapore and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are F STAR DELTA LTD, MEDITOPE BIOSCIENCES INC and F STAR BETA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 2 | |
#2 | Singapore | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Gorelik Leonid | 10 |
#2 | Belk Jonathan | 10 |
#3 | Sharkey Nathan J | 8 |
#4 | Jonathan Belk | 2 |
#5 | Nathan J Sharkey | 2 |
#6 | Leonid Gorelik | 2 |
#7 | Sharkey Nathan | 2 |
Publication | Filing date | Title |
---|---|---|
AU2017290709A1 | PD-L1-specific antibodies and methods of using the same |